AMG-305 is under clinical development by Amgen and currently in Phase I for Brea...
Leqembi is a game-changer for Alzheimer's. But the health care system needs to c...
The physician turned senator on how to balance the need to lower drug prices whi...
Novo Nordisk bought 457,222 meals to educate doctors about its drugs like Ozempi...
The FDA has granted full approval to the first therapy for Alzheimer’s disease c...
The generic trade group argued the “draconian regulations” come at a time when t...
Depression after traumatic brain injury is distinct, a new study finds, and ther...
Critics say any positive impact from the Alzheimer's drug Leqembi will not benef...
The study “can be used to evaluate risk of exposure and inform decisions about w...
The STAT Diversity and Inclusion Committee is proud to present STAT's inaugural ...
While watching “Jeopardy!”, “every single commercial break practically, I feel l...
Novo Nordisk will soon release results from a study that, if successful, could f...
“Shouldn’t we be focusing on doing what’s right for our community, not what’s ri...
Ending cancer is an achievable goal, but new Biden administration policies are s...
With weight loss and Alzheimer’s data, a dynamic duo powers Eli Lilly to new hei...
The new study “addresses some of the environmental pressures that contribute to ...
